A polypeptide is a chain of amino acid residues joined by peptide bonds. In the laboratory the molecule is used as a reference standard, a mass spectrometry calibrant, an enzyme substrate, an immunogen for antibody production, and a defined ligand in in-vitro binding work. Identity and purity are established by RP-HPLC and LC-MS.
- Polypeptide describes a covalent chain of amino acid residues and carries no claim about folding, function or regulatory status.
- Partial double bond character in the peptide C-N bond keeps the amide unit near planar, leaving two backbone dihedrals per residue as the conformational variables.
- Cis-trans isomerism at X-Pro bonds can produce two chromatographic peaks from a single compound, resolved diagnostically by raising column temperature.
- Deletion sequences from incomplete coupling are the characteristic impurity class in stepwise solid-phase synthesis, not random contamination.
- Chromatographic purity and net peptide content are different measurements, and only the second converts vial mass into molar concentration.
- Absorbance at 280 nm reflects tryptophan, tyrosine and cystine only, so aromatic-free polypeptides give no usable signal there.
Polypeptide, peptide, protein: where the words divide
Polypeptide names a structure, not a job. Any chain of amino acid residues joined head to tail by amide bonds is a polypeptide, whether it runs eight residues or eight hundred, whether it folds into something with a shape or drifts as a disordered string. The word carries no claim about activity, origin or purpose.
The subdivisions in common use are conventions and they overlap. Two residues is a dipeptide. Chains up to roughly twenty are usually called oligopeptides. Somewhere past thirty or fifty residues most writers switch to polypeptide, and once a chain folds into a defined tertiary structure with a known biological role people call it a protein. None of these boundaries has a chemical basis. Insulin, at 51 residues across two chains, is described as a protein in one paper and a polypeptide hormone in the next, and both usages are defensible. The IUPAC-IUBMB nomenclature recommendations fix the symbols and the writing conventions; they do not legislate a residue count at which one noun becomes another.
For laboratory work the useful question is never which noun applies. It is how many residues, in what order, with which modifications, and how much of that has actually been demonstrated on the lot in front of you.
- RP-HPLC at 214 nm — relative purity under stated conditions, nothing about mass
- LC-MS — mass consistent with the sequence, nothing about residue order
- MS/MS — sequence coverage, often incomplete on long chains
- Amino acid analysis — composition and net peptide content
- Karl Fischer and ion chromatography — the water and counterion you weighed
The peptide bond and what it fixes
The peptide bond is the amide formed between the α-carboxyl of one residue and the α-amino of the next, with loss of water. Two consequences of its electronic structure show up constantly at the bench.
First, the C-N bond has partial double bond character, because the nitrogen lone pair delocalises into the carbonyl. Rotation about it is hindered and the six atoms of the amide unit sit close to coplanar. Conformational freedom is therefore concentrated in the two dihedral angles either side of each α-carbon, which is why Ramachandran plots can describe the accessible conformational space of a polypeptide backbone with only two angles per residue.
Second, the trans arrangement dominates. Cis amides are strained except where the following residue is proline, whose pyrrolidine ring removes much of the penalty. Cis populations from a few percent to well above ten percent are ordinary at X-Pro bonds, and the interconversion is slow on both the NMR and the chromatographic timescale. A proline-containing peptide can give two well-resolved HPLC peaks that are the same compound in two rotameric states. Reading that as an impurity is one of the more common early misinterpretations, and the diagnostic is temperature: raise the column temperature and the peaks coalesce.
The chain also has direction. Numbering starts at the free amino terminus and runs to the carboxy terminus. The two ends carry different chemistry, a protonatable amine against a carboxylate, and that asymmetry plus the side-chain ionisation pattern gives the pH-dependent retention behaviour that reversed-phase and ion-exchange methods exploit.
How a sequence is written down
Sequences are written N-terminus first, reading left to right, in either the three-letter or the one-letter code. Both are standardised; the one-letter code is compact enough for arrays and database entries, the three-letter code is harder to misread on a printed certificate. A sequence written without stated direction is ambiguous and should be treated as incomplete documentation.
Modifications are carried as prefixes and suffixes on the same string, and they matter more than they look:
H-and-OHdenote a free amine and a free acid; writing them out removes any doubt.Ac-is N-terminal acetylation,-NH2is C-terminal amidation. Amidation removes a negative charge and changes the monoisotopic mass by roughly one dalton relative to the free acid, which is enough to identify the wrong material by LC-MS.- D-configured residues appear as lowercase one-letter codes or with a
D-prefix. A single stereocentre inversion is invisible to reversed-phase HPLC in many cases and invisible to mass spectrometry always. - Non-coded residues are spelled out: Aib for α-aminoisobutyric acid, Sar for sarcosine, Nle for norleucine, Orn for ornithine.
- Disulfide connectivity is written as bridges between numbered cysteines. A sequence containing two or more cysteines without stated connectivity does not define a molecule.
- Conjugates, whether PEG chains, fatty acids or fluorophores, are named with the attachment residue and the linker chemistry.
Salt form belongs in the same block. Peptides purified by reversed-phase chromatography with trifluoroacetic acid arrive as TFA salts unless a counterion exchange step was performed, and acetate is the usual alternative. The counterion contributes mass to the weighed powder while contributing nothing to the molar amount, and residual TFA is not inert in cell-based work.
What polypeptides are used for in a laboratory
The query in the title has a short answer and a long one. The short answer: defined polypeptides are used as measurement objects and as reagents. Everything below is a variation on one of those two roles.
| Role | What the polypeptide provides | What must be true of the lot |
|---|---|---|
| Reference standard, system suitability | Anchors retention time and detector response in an analytical method | Assigned purity by a stated method, known counterion, documented water content |
| Mass spectrometry calibration and tuning | Known monoisotopic masses spread across an m/z range | Sequence-verified identity, low salt burden, single dominant species |
| Protease, kinase and phosphatase substrate | A defined cleavage or modification site in a controlled context | Sequence purity, and absence of truncated or deletion sequences |
| Immunogen for antibody production | A short defined epitope, usually conjugated to a carrier protein | Terminal chemistry documented, for example a free cysteine for maleimide coupling |
| Epitope mapping and ELISA coating | Overlapping sequence sets covering a parent protein | Consistent length, comparable solubility, per-peptide identity data |
| In-vitro receptor binding and cell assays | A ligand at a known molar concentration | Net peptide content, since gross vial mass overstates the molar amount |
| Structural characterisation | Material for circular dichroism, NMR or crystallisation trials | High purity and a characterised aggregation state |
| Affinity capture and pull-down bait | An immobilised or biotinylated recognition sequence | Modification site and stoichiometry stated, not assumed |
Two points about that table. The right-hand column is where most failed experiments were decided, weeks before anyone ran the assay. And the roles are not interchangeable: a peptide adequate as an immunogen, where a mixed preparation of the correct sequence plus a few deletion products still raises usable antibodies, is not adequate as a quantitative reference standard, where the assigned value is the whole point.
Synthesis history is part of why. Stepwise solid-phase assembly, in the form Merrifield introduced in 1963 and which still underlies most commercial production, builds the chain one residue at a time. Incomplete coupling at any cycle yields a deletion sequence one residue short, which is chemically similar to the target and often chromatographically close to it. Deletion sequences, not random junk, are the characteristic impurity class in a synthetic polypeptide.
How the concept is measured
No single method characterises a polypeptide. Each answers a narrow question and is blind to the others, and a certificate that reports one number from one method is describing a fraction of the material.
| Method | Establishes | Blind to |
|---|---|---|
| RP-HPLC, UV at 214-220 nm | Relative peak area purity under stated gradient conditions | Co-eluting species, stereochemistry, counterion, water, endotoxin |
| ESI-LC-MS | Molecular mass consistent with the claimed sequence | Residue order; isobaric substitutions such as leucine for isoleucine |
| MS/MS fragmentation | Sequence coverage from b and y ion series | Complete coverage is not guaranteed; gaps are common in long chains |
| Amino acid analysis after acid hydrolysis | Composition and net peptide content by mass | Tryptophan is destroyed; Asn and Gln are read as Asp and Glu |
| Karl Fischer titration or TGA | Water in the powder | Everything else contributing to the weighed mass |
| Ion chromatography or 19F NMR | Counterion identity and amount, including residual TFA | Peptide identity |
| Circular dichroism | Secondary structure content in a given solvent | Sequence, purity, absolute concentration unless separately assigned |
| Size exclusion chromatography | Aggregate and oligomer content | Chemical modification within the monomer peak |
UV quantitation deserves a caution. Absorbance at 280 nm reflects tryptophan, tyrosine and cystine only, with tryptophan contributing the great majority. Pace and colleagues set out how to compute and measure those coefficients; the practical corollary is that a polypeptide with no aromatic residues has no useful 280 nm signal, and an A280 reading on such a material is measuring something other than the peptide. Backbone absorbance near 214 nm is universal but sensitive to solvent, buffer and mobile-phase composition, which is why it serves for relative purity rather than absolute concentration.
Purity figures are method-defined, always. Ninety-eight percent by a twenty-minute gradient on one column can read differently on another, and the number without the chromatogram, the gradient and the wavelength is a claim rather than a measurement.
Mass, content and molar concentration
The arithmetic that connects a vial label to an assay concentration is where net peptide content stops being an abstraction. Take a vial labelled 10 mg of a polypeptide with a molecular weight of 1200 g/mol, and a certificate stating net peptide content of 82 percent, the balance being counterion and water.
Peptide actually present:
10 mg × 0.82 = 8.2 mg
Brought into 2 mL of diluent:
8.2 mg ÷ 2 mL = 4.1 mg/mL
Expressed in molar terms:
4.1 g/L ÷ 1200 g/mol = 3.42 × 10⁻³ mol/L = 3.42 mM
Working from the gross label instead gives 5.0 mg/mL and 4.17 mM, an overstatement of about 22 percent carried silently through every dilution that follows. The vial concentration calculator handles the same arithmetic for other vial sizes and volumes. The same distinction governs price comparison: two vials quoted at the same figure per milligram are not the same purchase if their peptide contents differ, which is the calculation the cost per milligram tool exists to make explicit.
Diluent choice is part of the record, not a detail to fill in afterwards. Solubility, pH and the presence or absence of a preservative all belong in the preparation entry; the notes on bacteriostatic water cover what that choice changes analytically.
What competent documentation looks like
A certificate of analysis for a synthetic polypeptide should let a reader reconstruct how each number was obtained. That means a lot identifier that appears on the vial as well as the paper, the full sequence with modifications and any disulfide connectivity, molecular formula and both monoisotopic and average mass, counterion identity, purity with the method conditions attached, net peptide content with its method, water content, and dates.
Things that should prompt a question rather than a purchase order:
- A purity figure with no chromatogram and no gradient conditions.
- An identity claim with no mass spectrum, or a spectrum with no axis labels.
- No lot number, or a lot number that does not match the vial.
- Purity reported but peptide content absent, on material intended for quantitative work.
- Sequences containing multiple cysteines with no stated disulfide pattern.
- A single certificate reused across lots, identifiable by identical values and no date.
The reason to insist on this is narrow and practical. When an assay gives an unexpected result, the first question is whether the material matched the assumption in the protocol. Documentation that ties a sample back through the preparation record to a lot and its analytical data answers that in a few minutes. Our quality standard sets out which of these tests we require per lot and which are supplied on request.
Regulatory position
Polypeptide describes chemistry, so the class spans regulatory positions entirely. Some polypeptides are active ingredients in approved medicines manufactured under pharmaceutical quality systems, with monographs, sterility and endotoxin controls, and lot release testing. Others are laboratory reagents with no approved use in any jurisdiction. The structural description carries no implication about either.
Research-grade polypeptides are supplied for in-vitro and analytical work. A certificate of analysis covering identity and purity is a statement about chemical composition; it is not evidence of sterility, endotoxin control, formulation suitability or safety, and it has never been a lawful basis for administration to humans or animals.
Status verified 26 August 2026.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
Common questions
Is polypeptide just another word for protein?
Does 98 percent HPLC purity mean the vial contains 98 percent peptide?
Which single method proves identity?
Why does a proline-containing peptide sometimes give two HPLC peaks?
What does net peptide content change in practice?
More science guides
Sources
- IUPAC-IUBMB Joint Commission on Biochemical Nomenclature, recommendations on nomenclature and symbolism for amino acids and peptides. Establishes the one- and three-letter residue codes, N-terminus-first writing convention and the notation for modified and non-coded residues used throughout this article.
- Merrifield, Journal of the American Chemical Society, 1963. Introduces stepwise solid-phase peptide synthesis; supports the account of why deletion sequences from incomplete coupling are the characteristic impurity class in synthetic material.
- Pace and colleagues, Protein Science, 1995. Measurement and prediction of molar absorption coefficients from tryptophan, tyrosine and cystine content; supports the limits placed on UV quantitation at 280 nm.
- United States Pharmacopeia general chapters on chromatography and on amino acid analysis. Basis for treating purity as method-defined and for amino acid analysis after acid hydrolysis as the standard route to net peptide content.
